nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—CYP1B1—Mitoxantrone—multiple sclerosis	0.0599	0.0993	CbGbCtD
Paclitaxel—ABCC10—Methotrexate—multiple sclerosis	0.0459	0.0761	CbGbCtD
Paclitaxel—CYP19A1—Betamethasone—multiple sclerosis	0.0433	0.0717	CbGbCtD
Paclitaxel—ABCC1—Mitoxantrone—multiple sclerosis	0.0425	0.0705	CbGbCtD
Paclitaxel—ABCG2—Cladribine—multiple sclerosis	0.039	0.0647	CbGbCtD
Paclitaxel—ABCB11—Dexamethasone—multiple sclerosis	0.031	0.0515	CbGbCtD
Paclitaxel—CYP1B1—Dexamethasone—multiple sclerosis	0.031	0.0515	CbGbCtD
Paclitaxel—ABCG2—Mitoxantrone—multiple sclerosis	0.0285	0.0472	CbGbCtD
Paclitaxel—SLCO1B3—Methotrexate—multiple sclerosis	0.0256	0.0425	CbGbCtD
Paclitaxel—CYP19A1—Dexamethasone—multiple sclerosis	0.0252	0.0417	CbGbCtD
Paclitaxel—ABCC1—Methotrexate—multiple sclerosis	0.0177	0.0294	CbGbCtD
Paclitaxel—ABCC2—Dexamethasone—multiple sclerosis	0.0163	0.0271	CbGbCtD
Paclitaxel—ABCG2—Dexamethasone—multiple sclerosis	0.0148	0.0245	CbGbCtD
Paclitaxel—ABCB1—Methylprednisolone—multiple sclerosis	0.0141	0.0233	CbGbCtD
Paclitaxel—ABCC2—Methotrexate—multiple sclerosis	0.0131	0.0218	CbGbCtD
Paclitaxel—CYP3A4—Fingolimod—multiple sclerosis	0.0131	0.0217	CbGbCtD
Paclitaxel—ABCG2—Methotrexate—multiple sclerosis	0.0119	0.0197	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0109	0.0181	CbGbCtD
Paclitaxel—CYP3A7—Dexamethasone—multiple sclerosis	0.0109	0.0181	CbGbCtD
Paclitaxel—ABCB1—Mitoxantrone—multiple sclerosis	0.0103	0.017	CbGbCtD
Paclitaxel—ABCB1—Betamethasone—multiple sclerosis	0.00915	0.0152	CbGbCtD
Paclitaxel—ABCB1—Prednisolone—multiple sclerosis	0.00902	0.015	CbGbCtD
Paclitaxel—ABCB1—Prednisone—multiple sclerosis	0.00852	0.0141	CbGbCtD
Paclitaxel—CYP3A4—Methylprednisolone—multiple sclerosis	0.00843	0.014	CbGbCtD
Paclitaxel—CYP3A5—Dexamethasone—multiple sclerosis	0.00817	0.0136	CbGbCtD
Paclitaxel—CYP2C8—Dexamethasone—multiple sclerosis	0.00786	0.013	CbGbCtD
Paclitaxel—CYP3A4—Triamcinolone—multiple sclerosis	0.00639	0.0106	CbGbCtD
Paclitaxel—CYP3A4—Mitoxantrone—multiple sclerosis	0.00615	0.0102	CbGbCtD
Paclitaxel—CYP2C9—Dexamethasone—multiple sclerosis	0.00548	0.00909	CbGbCtD
Paclitaxel—CYP3A4—Betamethasone—multiple sclerosis	0.00548	0.00909	CbGbCtD
Paclitaxel—CYP3A4—Prednisolone—multiple sclerosis	0.00541	0.00897	CbGbCtD
Paclitaxel—ABCB1—Dexamethasone—multiple sclerosis	0.00532	0.00882	CbGbCtD
Paclitaxel—CYP3A4—Prednisone—multiple sclerosis	0.00511	0.00847	CbGbCtD
Paclitaxel—ABCB1—Methotrexate—multiple sclerosis	0.00428	0.00709	CbGbCtD
Paclitaxel—CYP3A4—Dexamethasone—multiple sclerosis	0.00319	0.00529	CbGbCtD
Paclitaxel—MAP2—nerve—multiple sclerosis	0.00307	0.0425	CbGeAlD
Paclitaxel—MAPT—retina—multiple sclerosis	0.00206	0.0284	CbGeAlD
Paclitaxel—MAP4—brainstem—multiple sclerosis	0.00168	0.0232	CbGeAlD
Paclitaxel—MAP4—retina—multiple sclerosis	0.00162	0.0224	CbGeAlD
Paclitaxel—MAPT—medulla oblongata—multiple sclerosis	0.00149	0.0206	CbGeAlD
Paclitaxel—MAPT—midbrain—multiple sclerosis	0.00136	0.0188	CbGeAlD
Paclitaxel—MAPT—spinal cord—multiple sclerosis	0.00132	0.0183	CbGeAlD
Paclitaxel—MAP2—brainstem—multiple sclerosis	0.00132	0.0183	CbGeAlD
Paclitaxel—TUBB8—nervous system—multiple sclerosis	0.00129	0.0178	CbGeAlD
Paclitaxel—MAP2—retina—multiple sclerosis	0.00127	0.0176	CbGeAlD
Paclitaxel—TUBB8—central nervous system—multiple sclerosis	0.00124	0.0171	CbGeAlD
Paclitaxel—TUBB—Azacitidine—Cladribine—multiple sclerosis	0.00122	0.708	CbGdCrCtD
Paclitaxel—MAP4—medulla oblongata—multiple sclerosis	0.00117	0.0162	CbGeAlD
Paclitaxel—MAP4—midbrain—multiple sclerosis	0.00107	0.0148	CbGeAlD
Paclitaxel—MAPT—cerebellum—multiple sclerosis	0.00105	0.0145	CbGeAlD
Paclitaxel—MAP4—spinal cord—multiple sclerosis	0.00104	0.0144	CbGeAlD
Paclitaxel—TUBB4A—brainstem—multiple sclerosis	0.00102	0.0141	CbGeAlD
Paclitaxel—TUBB4A—retina—multiple sclerosis	0.000983	0.0136	CbGeAlD
Paclitaxel—TUBB8—brain—multiple sclerosis	0.000983	0.0136	CbGeAlD
Paclitaxel—TUBB2B—retina—multiple sclerosis	0.00095	0.0132	CbGeAlD
Paclitaxel—MAP2—medulla oblongata—multiple sclerosis	0.00092	0.0127	CbGeAlD
Paclitaxel—TUBB3—nervous system—multiple sclerosis	0.000878	0.0121	CbGeAlD
Paclitaxel—MAP4—nervous system—multiple sclerosis	0.000878	0.0121	CbGeAlD
Paclitaxel—TUBB1—nervous system—multiple sclerosis	0.000858	0.0119	CbGeAlD
Paclitaxel—MAPT—brain—multiple sclerosis	0.000853	0.0118	CbGeAlD
Paclitaxel—MAP4—central nervous system—multiple sclerosis	0.000845	0.0117	CbGeAlD
Paclitaxel—TUBB3—central nervous system—multiple sclerosis	0.000845	0.0117	CbGeAlD
Paclitaxel—MAP2—midbrain—multiple sclerosis	0.000841	0.0116	CbGeAlD
Paclitaxel—TUBB1—central nervous system—multiple sclerosis	0.000826	0.0114	CbGeAlD
Paclitaxel—MAP4—cerebellum—multiple sclerosis	0.000826	0.0114	CbGeAlD
Paclitaxel—TUBB3—cerebellum—multiple sclerosis	0.000826	0.0114	CbGeAlD
Paclitaxel—MAP2—spinal cord—multiple sclerosis	0.00082	0.0114	CbGeAlD
Paclitaxel—BCL2—nervous system—multiple sclerosis	0.000798	0.011	CbGeAlD
Paclitaxel—BCL2—central nervous system—multiple sclerosis	0.000768	0.0106	CbGeAlD
Paclitaxel—TUBB4B—retina—multiple sclerosis	0.000767	0.0106	CbGeAlD
Paclitaxel—TUBB4A—medulla oblongata—multiple sclerosis	0.000711	0.00984	CbGeAlD
Paclitaxel—MAP2—nervous system—multiple sclerosis	0.000691	0.00956	CbGeAlD
Paclitaxel—TUBB2B—medulla oblongata—multiple sclerosis	0.000687	0.00951	CbGeAlD
Paclitaxel—TUBB3—brain—multiple sclerosis	0.000671	0.00928	CbGeAlD
Paclitaxel—MAP4—brain—multiple sclerosis	0.000671	0.00928	CbGeAlD
Paclitaxel—MAP2—central nervous system—multiple sclerosis	0.000665	0.00921	CbGeAlD
Paclitaxel—TUBB1—brain—multiple sclerosis	0.000656	0.00908	CbGeAlD
Paclitaxel—MAP2—cerebellum—multiple sclerosis	0.00065	0.009	CbGeAlD
Paclitaxel—TUBB—medulla oblongata—multiple sclerosis	0.00065	0.009	CbGeAlD
Paclitaxel—TUBB4A—midbrain—multiple sclerosis	0.00065	0.00899	CbGeAlD
Paclitaxel—TUBB2A—medulla oblongata—multiple sclerosis	0.000647	0.00895	CbGeAlD
Paclitaxel—TUBB6—medulla oblongata—multiple sclerosis	0.000638	0.00883	CbGeAlD
Paclitaxel—TUBB4A—spinal cord—multiple sclerosis	0.000634	0.00877	CbGeAlD
Paclitaxel—TUBB2B—midbrain—multiple sclerosis	0.000628	0.00869	CbGeAlD
Paclitaxel—TUBB2B—spinal cord—multiple sclerosis	0.000613	0.00848	CbGeAlD
Paclitaxel—BCL2—brain—multiple sclerosis	0.00061	0.00844	CbGeAlD
Paclitaxel—TUBB—midbrain—multiple sclerosis	0.000594	0.00822	CbGeAlD
Paclitaxel—TUBB2A—midbrain—multiple sclerosis	0.000591	0.00818	CbGeAlD
Paclitaxel—TUBB6—midbrain—multiple sclerosis	0.000583	0.00807	CbGeAlD
Paclitaxel—TUBB—spinal cord—multiple sclerosis	0.00058	0.00802	CbGeAlD
Paclitaxel—TUBB2A—spinal cord—multiple sclerosis	0.000577	0.00798	CbGeAlD
Paclitaxel—TUBB6—spinal cord—multiple sclerosis	0.000569	0.00787	CbGeAlD
Paclitaxel—ABCC10—medulla oblongata—multiple sclerosis	0.000558	0.00773	CbGeAlD
Paclitaxel—TUBB4B—medulla oblongata—multiple sclerosis	0.000554	0.00767	CbGeAlD
Paclitaxel—TUBB4A—nervous system—multiple sclerosis	0.000534	0.00739	CbGeAlD
Paclitaxel—MAP2—brain—multiple sclerosis	0.000528	0.00731	CbGeAlD
Paclitaxel—TUBB2B—nervous system—multiple sclerosis	0.000516	0.00714	CbGeAlD
Paclitaxel—TUBB4A—central nervous system—multiple sclerosis	0.000514	0.00712	CbGeAlD
Paclitaxel—ABCC10—midbrain—multiple sclerosis	0.00051	0.00706	CbGeAlD
Paclitaxel—TUBB4B—midbrain—multiple sclerosis	0.000507	0.00701	CbGeAlD
Paclitaxel—TUBB4A—cerebellum—multiple sclerosis	0.000503	0.00696	CbGeAlD
Paclitaxel—TUBB6—Azacitidine—Cladribine—multiple sclerosis	0.000502	0.292	CbGdCrCtD
Paclitaxel—ABCC10—spinal cord—multiple sclerosis	0.000498	0.00689	CbGeAlD
Paclitaxel—TUBB2B—central nervous system—multiple sclerosis	0.000497	0.00688	CbGeAlD
Paclitaxel—TUBB4B—spinal cord—multiple sclerosis	0.000494	0.00684	CbGeAlD
Paclitaxel—TUBB2A—nervous system—multiple sclerosis	0.000486	0.00672	CbGeAlD
Paclitaxel—TUBB2B—cerebellum—multiple sclerosis	0.000486	0.00672	CbGeAlD
Paclitaxel—TUBB6—nervous system—multiple sclerosis	0.000479	0.00663	CbGeAlD
Paclitaxel—TUBB2A—central nervous system—multiple sclerosis	0.000468	0.00647	CbGeAlD
Paclitaxel—TUBB6—central nervous system—multiple sclerosis	0.000461	0.00639	CbGeAlD
Paclitaxel—TUBB—cerebellum—multiple sclerosis	0.00046	0.00636	CbGeAlD
Paclitaxel—TUBB2A—cerebellum—multiple sclerosis	0.000457	0.00633	CbGeAlD
Paclitaxel—TUBB6—cerebellum—multiple sclerosis	0.000451	0.00624	CbGeAlD
Paclitaxel—TUBB4B—nervous system—multiple sclerosis	0.000417	0.00576	CbGeAlD
Paclitaxel—TUBB4A—brain—multiple sclerosis	0.000408	0.00565	CbGeAlD
Paclitaxel—TUBB4B—central nervous system—multiple sclerosis	0.000401	0.00555	CbGeAlD
Paclitaxel—ABCC10—cerebellum—multiple sclerosis	0.000395	0.00546	CbGeAlD
Paclitaxel—TUBB2B—brain—multiple sclerosis	0.000395	0.00546	CbGeAlD
Paclitaxel—TUBB4B—cerebellum—multiple sclerosis	0.000392	0.00542	CbGeAlD
Paclitaxel—TUBB—brain—multiple sclerosis	0.000373	0.00517	CbGeAlD
Paclitaxel—TUBB2A—brain—multiple sclerosis	0.000371	0.00514	CbGeAlD
Paclitaxel—TUBB6—brain—multiple sclerosis	0.000366	0.00507	CbGeAlD
Paclitaxel—CYP19A1—nervous system—multiple sclerosis	0.000353	0.00488	CbGeAlD
Paclitaxel—CYP19A1—central nervous system—multiple sclerosis	0.00034	0.0047	CbGeAlD
Paclitaxel—CYP1B1—nervous system—multiple sclerosis	0.00033	0.00457	CbGeAlD
Paclitaxel—ABCG2—medulla oblongata—multiple sclerosis	0.000327	0.00453	CbGeAlD
Paclitaxel—ABCC10—brain—multiple sclerosis	0.000321	0.00444	CbGeAlD
Paclitaxel—TUBB4B—brain—multiple sclerosis	0.000318	0.00441	CbGeAlD
Paclitaxel—CYP1B1—central nervous system—multiple sclerosis	0.000318	0.0044	CbGeAlD
Paclitaxel—CYP1B1—cerebellum—multiple sclerosis	0.00031	0.0043	CbGeAlD
Paclitaxel—ABCG2—midbrain—multiple sclerosis	0.000299	0.00414	CbGeAlD
Paclitaxel—ABCG2—spinal cord—multiple sclerosis	0.000292	0.00404	CbGeAlD
Paclitaxel—ABCC1—cerebellum—multiple sclerosis	0.000279	0.00386	CbGeAlD
Paclitaxel—CYP19A1—brain—multiple sclerosis	0.00027	0.00373	CbGeAlD
Paclitaxel—CYP1B1—brain—multiple sclerosis	0.000252	0.00349	CbGeAlD
Paclitaxel—ABCG2—cerebellum—multiple sclerosis	0.000231	0.0032	CbGeAlD
Paclitaxel—ABCC1—brain—multiple sclerosis	0.000227	0.00314	CbGeAlD
Paclitaxel—ABCB1—retina—multiple sclerosis	0.000223	0.00309	CbGeAlD
Paclitaxel—CYP2C8—brain—multiple sclerosis	0.000193	0.00267	CbGeAlD
Paclitaxel—ABCG2—brain—multiple sclerosis	0.000188	0.0026	CbGeAlD
Paclitaxel—CYP3A4—nervous system—multiple sclerosis	0.000171	0.00237	CbGeAlD
Paclitaxel—CYP3A4—central nervous system—multiple sclerosis	0.000165	0.00228	CbGeAlD
Paclitaxel—ABCB1—medulla oblongata—multiple sclerosis	0.000161	0.00223	CbGeAlD
Paclitaxel—ABCB1—midbrain—multiple sclerosis	0.000147	0.00204	CbGeAlD
Paclitaxel—ABCB1—spinal cord—multiple sclerosis	0.000144	0.00199	CbGeAlD
Paclitaxel—ABCB1—nervous system—multiple sclerosis	0.000121	0.00168	CbGeAlD
Paclitaxel—ABCB1—central nervous system—multiple sclerosis	0.000117	0.00161	CbGeAlD
Paclitaxel—ABCB1—cerebellum—multiple sclerosis	0.000114	0.00158	CbGeAlD
Paclitaxel—ABCB1—brain—multiple sclerosis	9.26e-05	0.00128	CbGeAlD
Paclitaxel—Nausea—Azathioprine—multiple sclerosis	7.23e-05	0.000324	CcSEcCtD
Paclitaxel—Tachycardia—Methylprednisolone—multiple sclerosis	7.23e-05	0.000324	CcSEcCtD
Paclitaxel—Skin disorder—Methylprednisolone—multiple sclerosis	7.19e-05	0.000323	CcSEcCtD
Paclitaxel—Malnutrition—Prednisone—multiple sclerosis	7.19e-05	0.000323	CcSEcCtD
Paclitaxel—Erythema—Prednisone—multiple sclerosis	7.19e-05	0.000323	CcSEcCtD
Paclitaxel—Hyperhidrosis—Triamcinolone—multiple sclerosis	7.18e-05	0.000322	CcSEcCtD
Paclitaxel—Hyperhidrosis—Methylprednisolone—multiple sclerosis	7.16e-05	0.000321	CcSEcCtD
Paclitaxel—Convulsion—Dexamethasone—multiple sclerosis	7.15e-05	0.000321	CcSEcCtD
Paclitaxel—Convulsion—Betamethasone—multiple sclerosis	7.15e-05	0.000321	CcSEcCtD
Paclitaxel—Hypertension—Dexamethasone—multiple sclerosis	7.12e-05	0.00032	CcSEcCtD
Paclitaxel—Hypertension—Betamethasone—multiple sclerosis	7.12e-05	0.00032	CcSEcCtD
Paclitaxel—Asthenia—Mitoxantrone—multiple sclerosis	7.06e-05	0.000317	CcSEcCtD
Paclitaxel—Myalgia—Dexamethasone—multiple sclerosis	7.03e-05	0.000315	CcSEcCtD
Paclitaxel—Myalgia—Betamethasone—multiple sclerosis	7.03e-05	0.000315	CcSEcCtD
Paclitaxel—Anxiety—Dexamethasone—multiple sclerosis	7e-05	0.000314	CcSEcCtD
Paclitaxel—Anxiety—Betamethasone—multiple sclerosis	7e-05	0.000314	CcSEcCtD
Paclitaxel—Discomfort—Betamethasone—multiple sclerosis	6.94e-05	0.000312	CcSEcCtD
Paclitaxel—Discomfort—Dexamethasone—multiple sclerosis	6.94e-05	0.000312	CcSEcCtD
Paclitaxel—Haemoglobin—Methotrexate—multiple sclerosis	6.93e-05	0.000311	CcSEcCtD
Paclitaxel—Hypotension—Methylprednisolone—multiple sclerosis	6.92e-05	0.000311	CcSEcCtD
Paclitaxel—Pain—Prednisolone—multiple sclerosis	6.9e-05	0.00031	CcSEcCtD
Paclitaxel—Haemorrhage—Methotrexate—multiple sclerosis	6.9e-05	0.00031	CcSEcCtD
Paclitaxel—Pharyngitis—Methotrexate—multiple sclerosis	6.85e-05	0.000307	CcSEcCtD
Paclitaxel—Urinary tract disorder—Methotrexate—multiple sclerosis	6.81e-05	0.000306	CcSEcCtD
Paclitaxel—Vision blurred—Prednisone—multiple sclerosis	6.77e-05	0.000304	CcSEcCtD
Paclitaxel—Urethral disorder—Methotrexate—multiple sclerosis	6.76e-05	0.000304	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	6.76e-05	0.000304	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	6.75e-05	0.000303	CcSEcCtD
Paclitaxel—Anaphylactic shock—Betamethasone—multiple sclerosis	6.73e-05	0.000302	CcSEcCtD
Paclitaxel—Anaphylactic shock—Dexamethasone—multiple sclerosis	6.73e-05	0.000302	CcSEcCtD
Paclitaxel—Oedema—Dexamethasone—multiple sclerosis	6.73e-05	0.000302	CcSEcCtD
Paclitaxel—Oedema—Betamethasone—multiple sclerosis	6.73e-05	0.000302	CcSEcCtD
Paclitaxel—Diarrhoea—Mitoxantrone—multiple sclerosis	6.73e-05	0.000302	CcSEcCtD
Paclitaxel—Insomnia—Triamcinolone—multiple sclerosis	6.71e-05	0.000301	CcSEcCtD
Paclitaxel—Insomnia—Methylprednisolone—multiple sclerosis	6.7e-05	0.000301	CcSEcCtD
Paclitaxel—Infection—Betamethasone—multiple sclerosis	6.69e-05	0.0003	CcSEcCtD
Paclitaxel—Infection—Dexamethasone—multiple sclerosis	6.69e-05	0.0003	CcSEcCtD
Paclitaxel—Ill-defined disorder—Prednisone—multiple sclerosis	6.67e-05	0.000299	CcSEcCtD
Paclitaxel—Paraesthesia—Triamcinolone—multiple sclerosis	6.66e-05	0.000299	CcSEcCtD
Paclitaxel—Feeling abnormal—Prednisolone—multiple sclerosis	6.65e-05	0.000299	CcSEcCtD
Paclitaxel—Paraesthesia—Methylprednisolone—multiple sclerosis	6.65e-05	0.000299	CcSEcCtD
Paclitaxel—Visual impairment—Methotrexate—multiple sclerosis	6.65e-05	0.000298	CcSEcCtD
Paclitaxel—Anaemia—Prednisone—multiple sclerosis	6.64e-05	0.000298	CcSEcCtD
Paclitaxel—Shock—Dexamethasone—multiple sclerosis	6.63e-05	0.000297	CcSEcCtD
Paclitaxel—Shock—Betamethasone—multiple sclerosis	6.63e-05	0.000297	CcSEcCtD
Paclitaxel—Dyspnoea—Triamcinolone—multiple sclerosis	6.62e-05	0.000297	CcSEcCtD
Paclitaxel—Nervous system disorder—Dexamethasone—multiple sclerosis	6.6e-05	0.000296	CcSEcCtD
Paclitaxel—Nervous system disorder—Betamethasone—multiple sclerosis	6.6e-05	0.000296	CcSEcCtD
Paclitaxel—Agitation—Prednisone—multiple sclerosis	6.6e-05	0.000296	CcSEcCtD
Paclitaxel—Thrombocytopenia—Dexamethasone—multiple sclerosis	6.59e-05	0.000296	CcSEcCtD
Paclitaxel—Thrombocytopenia—Betamethasone—multiple sclerosis	6.59e-05	0.000296	CcSEcCtD
Paclitaxel—Tachycardia—Betamethasone—multiple sclerosis	6.57e-05	0.000295	CcSEcCtD
Paclitaxel—Tachycardia—Dexamethasone—multiple sclerosis	6.57e-05	0.000295	CcSEcCtD
Paclitaxel—Angioedema—Prednisone—multiple sclerosis	6.57e-05	0.000295	CcSEcCtD
Paclitaxel—Dyspepsia—Triamcinolone—multiple sclerosis	6.53e-05	0.000293	CcSEcCtD
Paclitaxel—Erythema multiforme—Methotrexate—multiple sclerosis	6.52e-05	0.000293	CcSEcCtD
Paclitaxel—Dyspepsia—Methylprednisolone—multiple sclerosis	6.52e-05	0.000293	CcSEcCtD
Paclitaxel—Hyperhidrosis—Betamethasone—multiple sclerosis	6.51e-05	0.000292	CcSEcCtD
Paclitaxel—Hyperhidrosis—Dexamethasone—multiple sclerosis	6.51e-05	0.000292	CcSEcCtD
Paclitaxel—Malaise—Prednisone—multiple sclerosis	6.48e-05	0.000291	CcSEcCtD
Paclitaxel—Vertigo—Prednisone—multiple sclerosis	6.46e-05	0.00029	CcSEcCtD
Paclitaxel—Eye disorder—Methotrexate—multiple sclerosis	6.45e-05	0.000289	CcSEcCtD
Paclitaxel—Syncope—Prednisone—multiple sclerosis	6.44e-05	0.000289	CcSEcCtD
Paclitaxel—Tinnitus—Methotrexate—multiple sclerosis	6.43e-05	0.000289	CcSEcCtD
Paclitaxel—Anorexia—Betamethasone—multiple sclerosis	6.42e-05	0.000288	CcSEcCtD
Paclitaxel—Anorexia—Dexamethasone—multiple sclerosis	6.42e-05	0.000288	CcSEcCtD
Paclitaxel—Urticaria—Prednisolone—multiple sclerosis	6.41e-05	0.000288	CcSEcCtD
Paclitaxel—Cardiac disorder—Methotrexate—multiple sclerosis	6.4e-05	0.000287	CcSEcCtD
Paclitaxel—Fatigue—Triamcinolone—multiple sclerosis	6.4e-05	0.000287	CcSEcCtD
Paclitaxel—Fatigue—Methylprednisolone—multiple sclerosis	6.39e-05	0.000287	CcSEcCtD
Paclitaxel—Pain—Triamcinolone—multiple sclerosis	6.35e-05	0.000285	CcSEcCtD
Paclitaxel—Loss of consciousness—Prednisone—multiple sclerosis	6.32e-05	0.000284	CcSEcCtD
Paclitaxel—Hypotension—Dexamethasone—multiple sclerosis	6.29e-05	0.000282	CcSEcCtD
Paclitaxel—Hypotension—Betamethasone—multiple sclerosis	6.29e-05	0.000282	CcSEcCtD
Paclitaxel—Angiopathy—Methotrexate—multiple sclerosis	6.26e-05	0.000281	CcSEcCtD
Paclitaxel—Vomiting—Mitoxantrone—multiple sclerosis	6.26e-05	0.000281	CcSEcCtD
Paclitaxel—Immune system disorder—Methotrexate—multiple sclerosis	6.23e-05	0.00028	CcSEcCtD
Paclitaxel—Convulsion—Prednisone—multiple sclerosis	6.23e-05	0.000279	CcSEcCtD
Paclitaxel—Mediastinal disorder—Methotrexate—multiple sclerosis	6.22e-05	0.000279	CcSEcCtD
Paclitaxel—Hypertension—Prednisone—multiple sclerosis	6.2e-05	0.000279	CcSEcCtD
Paclitaxel—Rash—Mitoxantrone—multiple sclerosis	6.2e-05	0.000278	CcSEcCtD
Paclitaxel—Dermatitis—Mitoxantrone—multiple sclerosis	6.2e-05	0.000278	CcSEcCtD
Paclitaxel—Chills—Methotrexate—multiple sclerosis	6.19e-05	0.000278	CcSEcCtD
Paclitaxel—Headache—Mitoxantrone—multiple sclerosis	6.16e-05	0.000277	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	6.14e-05	0.000275	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	6.14e-05	0.000275	CcSEcCtD
Paclitaxel—Arthralgia—Prednisone—multiple sclerosis	6.12e-05	0.000275	CcSEcCtD
Paclitaxel—Myalgia—Prednisone—multiple sclerosis	6.12e-05	0.000275	CcSEcCtD
Paclitaxel—Feeling abnormal—Triamcinolone—multiple sclerosis	6.12e-05	0.000275	CcSEcCtD
Paclitaxel—Feeling abnormal—Methylprednisolone—multiple sclerosis	6.1e-05	0.000274	CcSEcCtD
Paclitaxel—Anxiety—Prednisone—multiple sclerosis	6.1e-05	0.000274	CcSEcCtD
Paclitaxel—Alopecia—Methotrexate—multiple sclerosis	6.1e-05	0.000274	CcSEcCtD
Paclitaxel—Insomnia—Dexamethasone—multiple sclerosis	6.09e-05	0.000273	CcSEcCtD
Paclitaxel—Insomnia—Betamethasone—multiple sclerosis	6.09e-05	0.000273	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	6.08e-05	0.000273	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	6.06e-05	0.000272	CcSEcCtD
Paclitaxel—Paraesthesia—Dexamethasone—multiple sclerosis	6.05e-05	0.000271	CcSEcCtD
Paclitaxel—Paraesthesia—Betamethasone—multiple sclerosis	6.05e-05	0.000271	CcSEcCtD
Paclitaxel—Discomfort—Prednisone—multiple sclerosis	6.04e-05	0.000271	CcSEcCtD
Paclitaxel—Mental disorder—Methotrexate—multiple sclerosis	6.04e-05	0.000271	CcSEcCtD
Paclitaxel—Erythema—Methotrexate—multiple sclerosis	6.01e-05	0.00027	CcSEcCtD
Paclitaxel—Malnutrition—Methotrexate—multiple sclerosis	6.01e-05	0.00027	CcSEcCtD
Paclitaxel—Hypersensitivity—Prednisolone—multiple sclerosis	5.95e-05	0.000267	CcSEcCtD
Paclitaxel—Dyspepsia—Dexamethasone—multiple sclerosis	5.93e-05	0.000266	CcSEcCtD
Paclitaxel—Dyspepsia—Betamethasone—multiple sclerosis	5.93e-05	0.000266	CcSEcCtD
Paclitaxel—Urticaria—Triamcinolone—multiple sclerosis	5.9e-05	0.000265	CcSEcCtD
Paclitaxel—Urticaria—Methylprednisolone—multiple sclerosis	5.88e-05	0.000264	CcSEcCtD
Paclitaxel—Dysgeusia—Methotrexate—multiple sclerosis	5.88e-05	0.000264	CcSEcCtD
Paclitaxel—Body temperature increased—Triamcinolone—multiple sclerosis	5.87e-05	0.000263	CcSEcCtD
Paclitaxel—Anaphylactic shock—Prednisone—multiple sclerosis	5.87e-05	0.000263	CcSEcCtD
Paclitaxel—Oedema—Prednisone—multiple sclerosis	5.87e-05	0.000263	CcSEcCtD
Paclitaxel—Abdominal pain—Methylprednisolone—multiple sclerosis	5.85e-05	0.000263	CcSEcCtD
Paclitaxel—Decreased appetite—Betamethasone—multiple sclerosis	5.85e-05	0.000263	CcSEcCtD
Paclitaxel—Decreased appetite—Dexamethasone—multiple sclerosis	5.85e-05	0.000263	CcSEcCtD
Paclitaxel—Nausea—Mitoxantrone—multiple sclerosis	5.84e-05	0.000262	CcSEcCtD
Paclitaxel—Infection—Prednisone—multiple sclerosis	5.83e-05	0.000262	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Betamethasone—multiple sclerosis	5.81e-05	0.000261	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	5.81e-05	0.000261	CcSEcCtD
Paclitaxel—Back pain—Methotrexate—multiple sclerosis	5.81e-05	0.000261	CcSEcCtD
Paclitaxel—Fatigue—Betamethasone—multiple sclerosis	5.81e-05	0.000261	CcSEcCtD
Paclitaxel—Fatigue—Dexamethasone—multiple sclerosis	5.81e-05	0.000261	CcSEcCtD
Paclitaxel—Shock—Prednisone—multiple sclerosis	5.77e-05	0.000259	CcSEcCtD
Paclitaxel—Pain—Dexamethasone—multiple sclerosis	5.76e-05	0.000259	CcSEcCtD
Paclitaxel—Pain—Betamethasone—multiple sclerosis	5.76e-05	0.000259	CcSEcCtD
Paclitaxel—Nervous system disorder—Prednisone—multiple sclerosis	5.75e-05	0.000258	CcSEcCtD
Paclitaxel—Tachycardia—Prednisone—multiple sclerosis	5.72e-05	0.000257	CcSEcCtD
Paclitaxel—Skin disorder—Prednisone—multiple sclerosis	5.7e-05	0.000256	CcSEcCtD
Paclitaxel—Hyperhidrosis—Prednisone—multiple sclerosis	5.67e-05	0.000255	CcSEcCtD
Paclitaxel—Vision blurred—Methotrexate—multiple sclerosis	5.66e-05	0.000254	CcSEcCtD
Paclitaxel—Anorexia—Prednisone—multiple sclerosis	5.59e-05	0.000251	CcSEcCtD
Paclitaxel—Ill-defined disorder—Methotrexate—multiple sclerosis	5.57e-05	0.00025	CcSEcCtD
Paclitaxel—Anaemia—Methotrexate—multiple sclerosis	5.55e-05	0.000249	CcSEcCtD
Paclitaxel—Feeling abnormal—Betamethasone—multiple sclerosis	5.55e-05	0.000249	CcSEcCtD
Paclitaxel—Feeling abnormal—Dexamethasone—multiple sclerosis	5.55e-05	0.000249	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Dexamethasone—multiple sclerosis	5.51e-05	0.000247	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Betamethasone—multiple sclerosis	5.51e-05	0.000247	CcSEcCtD
Paclitaxel—Hypersensitivity—Triamcinolone—multiple sclerosis	5.47e-05	0.000245	CcSEcCtD
Paclitaxel—Hypersensitivity—Methylprednisolone—multiple sclerosis	5.46e-05	0.000245	CcSEcCtD
Paclitaxel—Malaise—Methotrexate—multiple sclerosis	5.42e-05	0.000243	CcSEcCtD
Paclitaxel—Vertigo—Methotrexate—multiple sclerosis	5.4e-05	0.000242	CcSEcCtD
Paclitaxel—Leukopenia—Methotrexate—multiple sclerosis	5.38e-05	0.000241	CcSEcCtD
Paclitaxel—Urticaria—Dexamethasone—multiple sclerosis	5.35e-05	0.00024	CcSEcCtD
Paclitaxel—Urticaria—Betamethasone—multiple sclerosis	5.35e-05	0.00024	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Prednisone—multiple sclerosis	5.34e-05	0.00024	CcSEcCtD
Paclitaxel—Dizziness—Prednisolone—multiple sclerosis	5.34e-05	0.00024	CcSEcCtD
Paclitaxel—Asthenia—Triamcinolone—multiple sclerosis	5.33e-05	0.000239	CcSEcCtD
Paclitaxel—Abdominal pain—Dexamethasone—multiple sclerosis	5.32e-05	0.000239	CcSEcCtD
Paclitaxel—Body temperature increased—Dexamethasone—multiple sclerosis	5.32e-05	0.000239	CcSEcCtD
Paclitaxel—Abdominal pain—Betamethasone—multiple sclerosis	5.32e-05	0.000239	CcSEcCtD
Paclitaxel—Body temperature increased—Betamethasone—multiple sclerosis	5.32e-05	0.000239	CcSEcCtD
Paclitaxel—Asthenia—Methylprednisolone—multiple sclerosis	5.31e-05	0.000239	CcSEcCtD
Paclitaxel—Insomnia—Prednisone—multiple sclerosis	5.3e-05	0.000238	CcSEcCtD
Paclitaxel—Paraesthesia—Prednisone—multiple sclerosis	5.27e-05	0.000236	CcSEcCtD
Paclitaxel—Pruritus—Triamcinolone—multiple sclerosis	5.25e-05	0.000236	CcSEcCtD
Paclitaxel—Cough—Methotrexate—multiple sclerosis	5.24e-05	0.000235	CcSEcCtD
Paclitaxel—Pruritus—Methylprednisolone—multiple sclerosis	5.24e-05	0.000235	CcSEcCtD
Paclitaxel—Convulsion—Methotrexate—multiple sclerosis	5.2e-05	0.000234	CcSEcCtD
Paclitaxel—Dyspepsia—Prednisone—multiple sclerosis	5.16e-05	0.000232	CcSEcCtD
Paclitaxel—Chest pain—Methotrexate—multiple sclerosis	5.11e-05	0.00023	CcSEcCtD
Paclitaxel—Arthralgia—Methotrexate—multiple sclerosis	5.11e-05	0.00023	CcSEcCtD
Paclitaxel—Myalgia—Methotrexate—multiple sclerosis	5.11e-05	0.00023	CcSEcCtD
Paclitaxel—Decreased appetite—Prednisone—multiple sclerosis	5.1e-05	0.000229	CcSEcCtD
Paclitaxel—Rash—Prednisolone—multiple sclerosis	5.09e-05	0.000228	CcSEcCtD
Paclitaxel—Dermatitis—Prednisolone—multiple sclerosis	5.08e-05	0.000228	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	5.08e-05	0.000228	CcSEcCtD
Paclitaxel—Diarrhoea—Methylprednisolone—multiple sclerosis	5.07e-05	0.000227	CcSEcCtD
Paclitaxel—Fatigue—Prednisone—multiple sclerosis	5.06e-05	0.000227	CcSEcCtD
Paclitaxel—Headache—Prednisolone—multiple sclerosis	5.06e-05	0.000227	CcSEcCtD
Paclitaxel—Discomfort—Methotrexate—multiple sclerosis	5.05e-05	0.000227	CcSEcCtD
Paclitaxel—Constipation—Prednisone—multiple sclerosis	5.02e-05	0.000225	CcSEcCtD
Paclitaxel—Confusional state—Methotrexate—multiple sclerosis	4.94e-05	0.000222	CcSEcCtD
Paclitaxel—Dizziness—Triamcinolone—multiple sclerosis	4.91e-05	0.00022	CcSEcCtD
Paclitaxel—Anaphylactic shock—Methotrexate—multiple sclerosis	4.9e-05	0.00022	CcSEcCtD
Paclitaxel—Dizziness—Methylprednisolone—multiple sclerosis	4.9e-05	0.00022	CcSEcCtD
Paclitaxel—Infection—Methotrexate—multiple sclerosis	4.87e-05	0.000219	CcSEcCtD
Paclitaxel—Feeling abnormal—Prednisone—multiple sclerosis	4.83e-05	0.000217	CcSEcCtD
Paclitaxel—Asthenia—Dexamethasone—multiple sclerosis	4.83e-05	0.000217	CcSEcCtD
Paclitaxel—Asthenia—Betamethasone—multiple sclerosis	4.83e-05	0.000217	CcSEcCtD
Paclitaxel—Nervous system disorder—Methotrexate—multiple sclerosis	4.81e-05	0.000216	CcSEcCtD
Paclitaxel—Thrombocytopenia—Methotrexate—multiple sclerosis	4.8e-05	0.000215	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Prednisone—multiple sclerosis	4.8e-05	0.000215	CcSEcCtD
Paclitaxel—Nausea—Prednisolone—multiple sclerosis	4.79e-05	0.000215	CcSEcCtD
Paclitaxel—Pruritus—Dexamethasone—multiple sclerosis	4.76e-05	0.000214	CcSEcCtD
Paclitaxel—Pruritus—Betamethasone—multiple sclerosis	4.76e-05	0.000214	CcSEcCtD
Paclitaxel—Skin disorder—Methotrexate—multiple sclerosis	4.76e-05	0.000214	CcSEcCtD
Paclitaxel—Hyperhidrosis—Methotrexate—multiple sclerosis	4.74e-05	0.000213	CcSEcCtD
Paclitaxel—Vomiting—Triamcinolone—multiple sclerosis	4.72e-05	0.000212	CcSEcCtD
Paclitaxel—Vomiting—Methylprednisolone—multiple sclerosis	4.71e-05	0.000211	CcSEcCtD
Paclitaxel—Rash—Triamcinolone—multiple sclerosis	4.68e-05	0.00021	CcSEcCtD
Paclitaxel—Dermatitis—Triamcinolone—multiple sclerosis	4.68e-05	0.00021	CcSEcCtD
Paclitaxel—Anorexia—Methotrexate—multiple sclerosis	4.67e-05	0.00021	CcSEcCtD
Paclitaxel—Rash—Methylprednisolone—multiple sclerosis	4.67e-05	0.00021	CcSEcCtD
Paclitaxel—Dermatitis—Methylprednisolone—multiple sclerosis	4.67e-05	0.000209	CcSEcCtD
Paclitaxel—Urticaria—Prednisone—multiple sclerosis	4.66e-05	0.000209	CcSEcCtD
Paclitaxel—Headache—Triamcinolone—multiple sclerosis	4.65e-05	0.000209	CcSEcCtD
Paclitaxel—Headache—Methylprednisolone—multiple sclerosis	4.64e-05	0.000208	CcSEcCtD
Paclitaxel—Body temperature increased—Prednisone—multiple sclerosis	4.64e-05	0.000208	CcSEcCtD
Paclitaxel—Abdominal pain—Prednisone—multiple sclerosis	4.64e-05	0.000208	CcSEcCtD
Paclitaxel—Diarrhoea—Betamethasone—multiple sclerosis	4.61e-05	0.000207	CcSEcCtD
Paclitaxel—Diarrhoea—Dexamethasone—multiple sclerosis	4.61e-05	0.000207	CcSEcCtD
Paclitaxel—Hypotension—Methotrexate—multiple sclerosis	4.58e-05	0.000206	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	4.47e-05	0.0002	CcSEcCtD
Paclitaxel—Dizziness—Dexamethasone—multiple sclerosis	4.45e-05	0.0002	CcSEcCtD
Paclitaxel—Dizziness—Betamethasone—multiple sclerosis	4.45e-05	0.0002	CcSEcCtD
Paclitaxel—Insomnia—Methotrexate—multiple sclerosis	4.43e-05	0.000199	CcSEcCtD
Paclitaxel—Nausea—Triamcinolone—multiple sclerosis	4.41e-05	0.000198	CcSEcCtD
Paclitaxel—Paraesthesia—Methotrexate—multiple sclerosis	4.4e-05	0.000198	CcSEcCtD
Paclitaxel—Nausea—Methylprednisolone—multiple sclerosis	4.4e-05	0.000197	CcSEcCtD
Paclitaxel—Dyspnoea—Methotrexate—multiple sclerosis	4.37e-05	0.000196	CcSEcCtD
Paclitaxel—Somnolence—Methotrexate—multiple sclerosis	4.36e-05	0.000196	CcSEcCtD
Paclitaxel—Hypersensitivity—Prednisone—multiple sclerosis	4.32e-05	0.000194	CcSEcCtD
Paclitaxel—Dyspepsia—Methotrexate—multiple sclerosis	4.31e-05	0.000194	CcSEcCtD
Paclitaxel—Vomiting—Betamethasone—multiple sclerosis	4.28e-05	0.000192	CcSEcCtD
Paclitaxel—Vomiting—Dexamethasone—multiple sclerosis	4.28e-05	0.000192	CcSEcCtD
Paclitaxel—Decreased appetite—Methotrexate—multiple sclerosis	4.26e-05	0.000191	CcSEcCtD
Paclitaxel—Rash—Dexamethasone—multiple sclerosis	4.25e-05	0.000191	CcSEcCtD
Paclitaxel—Rash—Betamethasone—multiple sclerosis	4.25e-05	0.000191	CcSEcCtD
Paclitaxel—Dermatitis—Dexamethasone—multiple sclerosis	4.24e-05	0.00019	CcSEcCtD
Paclitaxel—Dermatitis—Betamethasone—multiple sclerosis	4.24e-05	0.00019	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Methotrexate—multiple sclerosis	4.23e-05	0.00019	CcSEcCtD
Paclitaxel—Fatigue—Methotrexate—multiple sclerosis	4.23e-05	0.00019	CcSEcCtD
Paclitaxel—Headache—Dexamethasone—multiple sclerosis	4.22e-05	0.000189	CcSEcCtD
Paclitaxel—Headache—Betamethasone—multiple sclerosis	4.22e-05	0.000189	CcSEcCtD
Paclitaxel—Asthenia—Prednisone—multiple sclerosis	4.21e-05	0.000189	CcSEcCtD
Paclitaxel—Pain—Methotrexate—multiple sclerosis	4.19e-05	0.000188	CcSEcCtD
Paclitaxel—Pruritus—Prednisone—multiple sclerosis	4.15e-05	0.000186	CcSEcCtD
Paclitaxel—Feeling abnormal—Methotrexate—multiple sclerosis	4.04e-05	0.000181	CcSEcCtD
Paclitaxel—Diarrhoea—Prednisone—multiple sclerosis	4.01e-05	0.00018	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.01e-05	0.00018	CcSEcCtD
Paclitaxel—Nausea—Betamethasone—multiple sclerosis	4e-05	0.00018	CcSEcCtD
Paclitaxel—Nausea—Dexamethasone—multiple sclerosis	4e-05	0.00018	CcSEcCtD
Paclitaxel—Urticaria—Methotrexate—multiple sclerosis	3.89e-05	0.000175	CcSEcCtD
Paclitaxel—Dizziness—Prednisone—multiple sclerosis	3.88e-05	0.000174	CcSEcCtD
Paclitaxel—Abdominal pain—Methotrexate—multiple sclerosis	3.87e-05	0.000174	CcSEcCtD
Paclitaxel—Body temperature increased—Methotrexate—multiple sclerosis	3.87e-05	0.000174	CcSEcCtD
Paclitaxel—Vomiting—Prednisone—multiple sclerosis	3.73e-05	0.000167	CcSEcCtD
Paclitaxel—Rash—Prednisone—multiple sclerosis	3.7e-05	0.000166	CcSEcCtD
Paclitaxel—Dermatitis—Prednisone—multiple sclerosis	3.69e-05	0.000166	CcSEcCtD
Paclitaxel—Headache—Prednisone—multiple sclerosis	3.67e-05	0.000165	CcSEcCtD
Paclitaxel—Hypersensitivity—Methotrexate—multiple sclerosis	3.61e-05	0.000162	CcSEcCtD
Paclitaxel—Asthenia—Methotrexate—multiple sclerosis	3.52e-05	0.000158	CcSEcCtD
Paclitaxel—BCL2—Immune System—IFIH1—multiple sclerosis	3.5e-05	0.000348	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.49e-05	0.000348	CbGpPWpGaD
Paclitaxel—Nausea—Prednisone—multiple sclerosis	3.48e-05	0.000156	CcSEcCtD
Paclitaxel—Pruritus—Methotrexate—multiple sclerosis	3.47e-05	0.000156	CcSEcCtD
Paclitaxel—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.45e-05	0.000344	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—MAPK1—multiple sclerosis	3.44e-05	0.000342	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.43e-05	0.000342	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—GPC5—multiple sclerosis	3.43e-05	0.000342	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.42e-05	0.000341	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—RRM1—multiple sclerosis	3.37e-05	0.000335	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—HLA-B—multiple sclerosis	3.36e-05	0.000335	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.36e-05	0.000335	CbGpPWpGaD
Paclitaxel—Diarrhoea—Methotrexate—multiple sclerosis	3.35e-05	0.000151	CcSEcCtD
Paclitaxel—NR1I2—Gene Expression—VDR—multiple sclerosis	3.35e-05	0.000333	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	3.33e-05	0.000332	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—TNFAIP3—multiple sclerosis	3.27e-05	0.000326	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	3.26e-05	0.000325	CbGpPWpGaD
Paclitaxel—Dizziness—Methotrexate—multiple sclerosis	3.24e-05	0.000145	CcSEcCtD
Paclitaxel—ABCB11—Metabolism—RRM1—multiple sclerosis	3.17e-05	0.000315	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	3.15e-05	0.000314	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	3.15e-05	0.000314	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CYP24A1—multiple sclerosis	3.14e-05	0.000313	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CYP27B1—multiple sclerosis	3.14e-05	0.000313	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.13e-05	0.000312	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.13e-05	0.000312	CbGpPWpGaD
Paclitaxel—Vomiting—Methotrexate—multiple sclerosis	3.12e-05	0.00014	CcSEcCtD
Paclitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	3.1e-05	0.000309	CbGpPWpGaD
Paclitaxel—Rash—Methotrexate—multiple sclerosis	3.09e-05	0.000139	CcSEcCtD
Paclitaxel—Dermatitis—Methotrexate—multiple sclerosis	3.09e-05	0.000139	CcSEcCtD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.08e-05	0.000307	CbGpPWpGaD
Paclitaxel—Headache—Methotrexate—multiple sclerosis	3.07e-05	0.000138	CcSEcCtD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.07e-05	0.000306	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	3.05e-05	0.000303	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CYP27B1—multiple sclerosis	3.04e-05	0.000302	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CYP24A1—multiple sclerosis	3.04e-05	0.000302	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.97e-05	0.000296	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD28—multiple sclerosis	2.94e-05	0.000293	CbGpPWpGaD
Paclitaxel—Nausea—Methotrexate—multiple sclerosis	2.91e-05	0.000131	CcSEcCtD
Paclitaxel—BCL2—Immune System—PTPRC—multiple sclerosis	2.89e-05	0.000288	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CCR2—multiple sclerosis	2.89e-05	0.000288	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—GPC5—multiple sclerosis	2.88e-05	0.000287	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—GPC5—multiple sclerosis	2.87e-05	0.000286	CbGpPWpGaD
Paclitaxel—TUBB6—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.87e-05	0.000285	CbGpPWpGaD
Paclitaxel—TUBB2B—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.87e-05	0.000285	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—POMC—multiple sclerosis	2.86e-05	0.000284	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—POMC—multiple sclerosis	2.86e-05	0.000284	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—TLR4—multiple sclerosis	2.85e-05	0.000284	CbGpPWpGaD
Paclitaxel—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.81e-05	0.00028	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—SRM—multiple sclerosis	2.81e-05	0.00028	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—CCL2—multiple sclerosis	2.79e-05	0.000278	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—CCL2—multiple sclerosis	2.79e-05	0.000278	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HLA-DPB1—multiple sclerosis	2.79e-05	0.000278	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—GPC5—multiple sclerosis	2.78e-05	0.000277	CbGpPWpGaD
Paclitaxel—TUBB3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.77e-05	0.000276	CbGpPWpGaD
Paclitaxel—NR1I2—Generic Transcription Pathway—MYC—multiple sclerosis	2.76e-05	0.000275	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CYP24A1—multiple sclerosis	2.76e-05	0.000275	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CYP27B1—multiple sclerosis	2.76e-05	0.000275	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—POMC—multiple sclerosis	2.76e-05	0.000275	CbGpPWpGaD
Paclitaxel—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	2.75e-05	0.000274	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	2.74e-05	0.000273	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	2.74e-05	0.000273	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	2.72e-05	0.000271	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—IL2—multiple sclerosis	2.71e-05	0.00027	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—CCL2—multiple sclerosis	2.7e-05	0.000269	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD40—multiple sclerosis	2.69e-05	0.000268	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—ITGA4—multiple sclerosis	2.69e-05	0.000268	CbGpPWpGaD
Paclitaxel—TUBB2A—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.68e-05	0.000267	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.68e-05	0.000267	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—POMC—multiple sclerosis	2.67e-05	0.000266	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IFNB1—multiple sclerosis	2.67e-05	0.000266	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	2.66e-05	0.000265	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CTLA4—multiple sclerosis	2.65e-05	0.000264	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—CD80—multiple sclerosis	2.63e-05	0.000262	CbGpPWpGaD
Paclitaxel—TUBB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.62e-05	0.000261	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—CCL2—multiple sclerosis	2.61e-05	0.00026	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—POMC—multiple sclerosis	2.61e-05	0.00026	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.61e-05	0.00026	CbGpPWpGaD
Paclitaxel—CYP3A5—Biological oxidations—POMC—multiple sclerosis	2.6e-05	0.000259	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	2.6e-05	0.000259	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.6e-05	0.000259	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—CCL2—multiple sclerosis	2.56e-05	0.000255	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GPC5—multiple sclerosis	2.53e-05	0.000252	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GPC5—multiple sclerosis	2.5e-05	0.000249	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.46e-05	0.000245	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SRM—multiple sclerosis	2.43e-05	0.000242	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—RRM1—multiple sclerosis	2.39e-05	0.000238	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—RRM1—multiple sclerosis	2.38e-05	0.000237	CbGpPWpGaD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.35e-05	0.000234	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—POMC—multiple sclerosis	2.35e-05	0.000234	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—VCAM1—multiple sclerosis	2.34e-05	0.000233	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HLA-DQA1—multiple sclerosis	2.33e-05	0.000232	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—RRM1—multiple sclerosis	2.3e-05	0.000229	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—CCL2—multiple sclerosis	2.29e-05	0.000229	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.29e-05	0.000228	CbGpPWpGaD
Paclitaxel—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.28e-05	0.000227	CbGpPWpGaD
Paclitaxel—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.25e-05	0.000225	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.24e-05	0.000223	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—RPL5—multiple sclerosis	2.23e-05	0.000222	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—TYK2—multiple sclerosis	2.22e-05	0.000221	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—MYC—multiple sclerosis	2.2e-05	0.000219	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HLA-DQB1—multiple sclerosis	2.18e-05	0.000217	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.15e-05	0.000214	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	2.15e-05	0.000214	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—POMC—multiple sclerosis	2.15e-05	0.000214	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—SLC11A1—multiple sclerosis	2.14e-05	0.000213	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SRM—multiple sclerosis	2.12e-05	0.000211	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.11e-05	0.00021	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.11e-05	0.00021	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD86—multiple sclerosis	2.1e-05	0.000209	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—CCL2—multiple sclerosis	2.1e-05	0.000209	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—RRM1—multiple sclerosis	2.09e-05	0.000209	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—RRM1—multiple sclerosis	2.08e-05	0.000207	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD40LG—multiple sclerosis	2.06e-05	0.000205	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.05e-05	0.000205	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.04e-05	0.000204	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD8A—multiple sclerosis	2.04e-05	0.000203	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—CD4—multiple sclerosis	2.01e-05	0.0002	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SRM—multiple sclerosis	1.98e-05	0.000197	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	1.98e-05	0.000197	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	1.98e-05	0.000197	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.97e-05	0.000196	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—MYC—multiple sclerosis	1.96e-05	0.000196	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HLA-B—multiple sclerosis	1.96e-05	0.000195	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.94e-05	0.000194	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—BCHE—multiple sclerosis	1.93e-05	0.000193	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.92e-05	0.000192	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—MAPK1—multiple sclerosis	1.92e-05	0.000191	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.85e-05	0.000185	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.85e-05	0.000184	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL2RA—multiple sclerosis	1.84e-05	0.000183	CbGpPWpGaD
Paclitaxel—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.84e-05	0.000183	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—BCHE—multiple sclerosis	1.82e-05	0.000181	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—MYC—multiple sclerosis	1.82e-05	0.000181	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.82e-05	0.000181	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HLA-A—multiple sclerosis	1.82e-05	0.000181	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GPC5—multiple sclerosis	1.81e-05	0.00018	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.79e-05	0.000178	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	1.78e-05	0.000177	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	1.71e-05	0.000171	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	1.71e-05	0.000171	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CD28—multiple sclerosis	1.71e-05	0.00017	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.68e-05	0.000167	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—MYC—multiple sclerosis	1.66e-05	0.000166	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—TLR4—multiple sclerosis	1.66e-05	0.000165	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HLA-DRB1—multiple sclerosis	1.66e-05	0.000165	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	1.63e-05	0.000162	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—MYC—multiple sclerosis	1.63e-05	0.000162	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.59e-05	0.000159	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—ICAM1—multiple sclerosis	1.59e-05	0.000159	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—MAPK1—multiple sclerosis	1.59e-05	0.000158	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.59e-05	0.000158	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.57e-05	0.000156	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.53e-05	0.000153	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD80—multiple sclerosis	1.53e-05	0.000153	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.5e-05	0.000149	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.49e-05	0.000149	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.49e-05	0.000149	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—MYC—multiple sclerosis	1.49e-05	0.000148	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—MAPK1—multiple sclerosis	1.46e-05	0.000145	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.45e-05	0.000145	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.45e-05	0.000144	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—MAPK1—multiple sclerosis	1.41e-05	0.000141	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.4e-05	0.000139	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.4e-05	0.000139	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.4e-05	0.000139	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.39e-05	0.000139	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.37e-05	0.000137	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—BCHE—multiple sclerosis	1.37e-05	0.000137	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—BCHE—multiple sclerosis	1.37e-05	0.000136	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GPC5—multiple sclerosis	1.37e-05	0.000136	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.36e-05	0.000136	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—MYC—multiple sclerosis	1.33e-05	0.000133	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—BCHE—multiple sclerosis	1.32e-05	0.000132	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SRM—multiple sclerosis	1.31e-05	0.00013	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.3e-05	0.000129	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—TYK2—multiple sclerosis	1.29e-05	0.000129	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.28e-05	0.000127	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CD86—multiple sclerosis	1.22e-05	0.000121	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IFNG—multiple sclerosis	1.21e-05	0.000121	CbGpPWpGaD
Paclitaxel—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.21e-05	0.000121	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.21e-05	0.00012	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—BCHE—multiple sclerosis	1.2e-05	0.00012	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.19e-05	0.000119	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD4—multiple sclerosis	1.17e-05	0.000117	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—APOE—multiple sclerosis	1.16e-05	0.000116	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—RRM1—multiple sclerosis	1.13e-05	0.000113	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—APOE—multiple sclerosis	1.09e-05	0.000109	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—IL6—multiple sclerosis	1.09e-05	0.000108	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL1B—multiple sclerosis	1.08e-05	0.000108	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CCR5—multiple sclerosis	1.08e-05	0.000107	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL2—multiple sclerosis	1.08e-05	0.000107	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.06e-05	0.000105	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HLA-A—multiple sclerosis	1.05e-05	0.000105	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.04e-05	0.000104	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.04e-05	0.000104	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.02e-05	0.000102	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.01e-05	0.0001	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—POMC—multiple sclerosis	9.99e-06	9.95e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—APOE—multiple sclerosis	9.82e-06	9.78e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	9.73e-06	9.69e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—POMC—multiple sclerosis	9.4e-06	9.36e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	9.2e-06	9.17e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	9.2e-06	9.17e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—ALB—multiple sclerosis	9.11e-06	9.07e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—STAT3—multiple sclerosis	9.06e-06	9.02e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CD80—multiple sclerosis	8.87e-06	8.84e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.66e-06	8.63e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—BCHE—multiple sclerosis	8.61e-06	8.58e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—ALB—multiple sclerosis	8.57e-06	8.54e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GPC5—multiple sclerosis	8.42e-06	8.38e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—APOE—multiple sclerosis	8.26e-06	8.22e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—MAPK1—multiple sclerosis	8.23e-06	8.2e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—APOE—multiple sclerosis	8.22e-06	8.19e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.2e-06	8.17e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—APOE—multiple sclerosis	7.95e-06	7.92e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.89e-06	7.86e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TYK2—multiple sclerosis	7.49e-06	7.46e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—BCHE—multiple sclerosis	7.46e-06	7.43e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—APOE—multiple sclerosis	7.23e-06	7.21e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—APOE—multiple sclerosis	7.17e-06	7.14e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—POMC—multiple sclerosis	7.09e-06	7.07e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—POMC—multiple sclerosis	7.06e-06	7.03e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.05e-06	7.02e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—RRM1—multiple sclerosis	6.97e-06	6.95e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—POMC—multiple sclerosis	6.83e-06	6.8e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CD4—multiple sclerosis	6.78e-06	6.75e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.54e-06	6.51e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—BCHE—multiple sclerosis	6.5e-06	6.48e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ALB—multiple sclerosis	6.47e-06	6.44e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ALB—multiple sclerosis	6.44e-06	6.41e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.42e-06	6.4e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL6—multiple sclerosis	6.33e-06	6.3e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ALB—multiple sclerosis	6.23e-06	6.2e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—POMC—multiple sclerosis	6.21e-06	6.19e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—POMC—multiple sclerosis	6.16e-06	6.14e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—BCHE—multiple sclerosis	6.07e-06	6.05e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ALB—multiple sclerosis	5.67e-06	5.64e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ALB—multiple sclerosis	5.62e-06	5.59e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—STAT3—multiple sclerosis	5.25e-06	5.23e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—APOE—multiple sclerosis	5.18e-06	5.16e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MYC—multiple sclerosis	4.87e-06	4.86e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TGFB1—multiple sclerosis	4.86e-06	4.84e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MAPK1—multiple sclerosis	4.77e-06	4.75e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—APOE—multiple sclerosis	4.49e-06	4.47e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—POMC—multiple sclerosis	4.45e-06	4.43e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ALB—multiple sclerosis	4.06e-06	4.04e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.01e-06	3.99e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—APOE—multiple sclerosis	3.91e-06	3.9e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—POMC—multiple sclerosis	3.86e-06	3.84e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IL6—multiple sclerosis	3.66e-06	3.65e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—APOE—multiple sclerosis	3.65e-06	3.64e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ALB—multiple sclerosis	3.52e-06	3.5e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—POMC—multiple sclerosis	3.36e-06	3.35e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—POMC—multiple sclerosis	3.14e-06	3.13e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ALB—multiple sclerosis	3.06e-06	3.05e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ALB—multiple sclerosis	2.86e-06	2.85e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—APOE—multiple sclerosis	2.41e-06	2.4e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—POMC—multiple sclerosis	2.07e-06	2.06e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALB—multiple sclerosis	1.89e-06	1.88e-05	CbGpPWpGaD
